Healthcare -
Biotechnology - NASDAQ - US
$ 11.465
-3.17 %
$ 37.3 M
Market Cap
-0.68
P/E
Price Target
Average
235.80%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
26.73%
Net Income
Estimate
9.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Surrozen, Inc.
Wall Street analysts predict an average 1-year price target for SRZN of $38.5 , with forecasts ranging from
a
low of
$32 to a high of $45 .
SRZN Lowest Price Target
Wall Street Target
32 USD
179.11%
SRZN Average Price Target
Wall Street Target
38.5 USD
235.80%
SRZN Highest Price Target
Wall Street Target
45 USD
292.50%
REVENUE FORECAST
Revenue Forecast Chart SRZN
EBIT FORECAST
EBIT Forecast Chart SRZN
NET INCOME FORECAST
Net Income Chart SRZN